Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
107.98
(
0.47%
)
Bitcoin
77,029.48
(
-0.49%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: pcrutch post# 140529

Friday, 04/20/2012 10:33:59 AM

Friday, April 20, 2012 10:33:59 AM

Post# of 257580

VRTX—I have actually heard some very positive comments (from a fund manager and a biopharma intelligence exec) about the nukes that VRTX-Alios are developing.

I too expect the nukes from Alios to be good ones, but jq1234 was commenting on VRTX’s lack of an NS5A inhibitor.

p.s. What exactly is a biophrama intelligence executive? :- )

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today